The repeated administration of DSS causes an amplification of the inflammatory response in ulcerative colitis with an exaggerated production of ROS, TNF-alpha, IL-1 beta, and IL-6 which will be responsible for the severity of the colitis and the appearance of symptoms related to inflammatory bowel diseases [51, 52]. This evidence concerns the gene TNF and ulcerative colitis.